基于组织学参考的前列腺癌68Ga-HBED-CC PSMA PET/CT与MRI局灶剂量递增计划研究
本研究纳入10例接受PSMA PET/CT和mpMRI后行前列腺切除术的原发性前列腺癌患者,基于PET、MRI及两者联合勾画大体肿瘤体积并制定两种剂量递增计划。结果显示基于联合GTV的IMRT剂量递增可行,联合GTV Boost的TCP-histo显著高于单独MRI或PET计划,而直肠和膀胱NTCP无显著增加或仅轻微增加。
要点
- 基于mpMRI、PSMA PET/CT及两者联合的GTV进行IMRT剂量递增是可行的。
- Plan95union的TCP-histo为99.7%(范围97%-100%),显著高于Plan95MRI和Plan95PET(均p=0.008)。
- Plan95MRI的NTCP-直肠显著低于Plan95union(p=0.012),其余计划间NTCP无显著差异(p>0.05)。
核心结论
- 基于mpMRI、PSMA PET/CT及两者联合勾画的GTV进行IMRT剂量递增是可行的。
- 联合GTV Boost相比其他计划带来显著更高的TCP-histo,且NTCP无增加或仅轻微增加。
研究设计与样本
- 计划研究,纳入10例接受PSMA PET/CT和mpMRI后行前列腺切除术的原发性前列腺癌患者。
- 基于PET(GTV-PET)、mpMRI(GTV-MRI)及两者联合(GTV-union)勾画三个大体肿瘤体积。
- 每个GTV生成两种计划:Plan95为全前列腺IMRT 77 Gy/35次并同步Boost至95 Gy;Plan80为全前列腺IMRT 76 Gy/38次并同步Boost至80 Gy。
- TCP基于组织学参考勾画的GTV-histo计算,NTCP评估膀胱和直肠。
主要发现
- 所有治疗计划均达到已发表方案的剂量约束。
- Plan95union和Plan80union的平均TCP-histo分别为99.7%(范围97%-100%)和75.5%(范围33%-95%)。
- Plan95union的TCP-histo显著高于Plan95MRI(p=0.008)和Plan95PET(p=0.008)。
- Plan80union的TCP-histo显著高于Plan80MRI(p=0.012),但与Plan80PET无显著差异(p=0.472)。
- Plan95MRI的NTCP-直肠显著低于Plan95union(p=0.012),其余计划间NTCP-直肠和NTCP-膀胱均无显著差异(p>0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Focal radiation therapy has gained of interest in treatment of patients with primary prostate cancer (PCa). The question of how to define the intraprostatic boost volume is still open. Previous studies showed that multiparametric MRI (mpMRI) or PSMA PET alone could be used for boost volume definition. However, other studies proposed that the combined usage of both has the highest sensitivity in detection of intraprostatic lesions. The aim of this study was to demonstrate the feasibility and to evaluate the tumour control probability (TCP) and normal tissue complication probability (NTCP) of radiation therapy dose painting using 68Ga-HBED-CC PSMA PET/CT, mpMRI or the combination of both in primary PCa. METHODS: Ten patients underwent PSMA PET/CT and mpMRI followed by prostatectomy. Three gross tumour volumes (GTVs) were created based on PET (GTV-PET), mpMRI (GTV-MRI) and the union of both (GTV-union). Two plans were generated for each GTV. Plan95 consisted of whole-prostate IMRT to 77 Gy in 35 fractions and a simultaneous boost to 95 Gy (Plan95PET/Plan95MRI/Plan95union). Plan80 consisted of whole-prostate IMRT to 76 Gy in 38 fractions and a simultaneous boost to 80 Gy (Plan80PET/Plan80MRI/Plan80union). TCPs were calculated for GTV-histo (TCP-histo), which was delineated based on PCa distribution in co-registered histology slices. NTCPs were assessed for bladder and rectum. RESULTS: Dose constraints of published protocols were reached in every treatment plan. Mean TCP-histo were 99.7% (range: 97%-100%) and 75.5% (range: 33%-95%) for Plan95union and Plan80union, respectively. Plan95union had significantly higher TCP-histo values than Plan95MRI (p = 0.008) and Plan95PET (p = 0.008). Plan80union had significantly higher TCP-histo values than Plan80MRI (p = 0.012), but not than Plan80PET (p = 0.472). Plan95MRI had significantly lower NTCP-rectum than Plan95union (p = 0.012). No significant differences in NTCP-rectum and NTCP-bladder were observed for all other plans (p > 0.05). CONCLUSIONS: IMRT dose escalation on GTVs based on mpMRI, PSMA PET/CT and the combination of both was feasible. Boosting GTV-union resulted in significantly higher TCP-histo with no or minimal increase of NTCPs compared to the other plans.
引用
- Zamboglou C, Thomann B, Koubar K, et al. Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference. Radiat Oncol. 2018. PMID: 29716617. doi:10.1186/s13014-018-1036-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。